{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T20:08:18Z","timestamp":1766088498138,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.clon.2025.103937","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:20:48Z","timestamp":1757550048000},"page":"103937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Radiating Excellence: A Decade of Pioneering Radiotherapy Trials and Collaborative Leadership at Leeds Cancer Research UK Clinical Trials Unit"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7176-904X","authenticated-orcid":false,"given":"F.","family":"Slevin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8758-7163","authenticated-orcid":false,"given":"E.M.","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hockaday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2884-4849","authenticated-orcid":false,"given":"J.","family":"Kendall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Noutch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.B.","family":"Oughton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Sebag-Montefiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.clon.2025.103937_bib1","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jamaoncol.2018.0887","article-title":"Characteristics of Radiotherapy Trials Compared With Other Oncological Clinical Trials in the Past 10 Years","volume":"4","author":"Liu","year":"2018","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.clon.2025.103937_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clon.2019.09.043","article-title":"CTRad 10 Years On: From 10-point Plan to Top 10 Achievements","volume":"32","author":"Chalmers","year":"2020","journal-title":"Clin Oncol"},{"issue":"1","key":"10.1016\/j.clon.2025.103937_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13063-017-2378-5","article-title":"What are the main inefficiencies in trial conduct: a survey of UKCRC registered clinical trials units in the UK","volume":"19","author":"Duley","year":"2018","journal-title":"Trials"},{"issue":"4","key":"10.1016\/j.clon.2025.103937_bib4","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/S1470-2045(24)00664-8","article-title":"Innovative, early-phase clinical trials of drug\u2013radiotherapy combinations","volume":"26","author":"Levy","year":"2025","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.clon.2025.103937_bib5","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1158\/1078-0432.CCR-18-2466","article-title":"Clinical Development of Novel Drug-Radiotherapy Combinations","volume":"25","author":"Ahmad","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.clon.2025.103937_bib6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrclinonc.2016.79","article-title":"Clinical development of new drug\u2013radiotherapy combinations","volume":"13","author":"Sharma","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"17","key":"10.1016\/j.clon.2025.103937_bib7","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1158\/1078-0432.CCR-21-4087","article-title":"A Road Map for Designing Phase I Clinical Trials of Radiotherapy-Novel Agent Combinations","volume":"28","author":"Brown","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clon.2025.103937_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ctro.2020.09.006","article-title":"CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer","volume":"25","author":"Walls","year":"2020","journal-title":"Clin Translational Radiat Oncol"},{"issue":"11","key":"10.1016\/j.clon.2025.103937_bib9","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.clon.2016.08.004","article-title":"The Challenges Faced in Developing Novel Drug Radiation Combinations in Non-small Cell Lung Cancer","volume":"28","author":"Harrow","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clon.2025.103937_bib10","series-title":"JCO precis oncol","article-title":"Implementation of the Time-to-Event Continuous Reassessment Method Design in a Phase I Platform Trial Testing Novel Radiotherapy-Drug Combinations-CONCORDE","author":"Walker","year":"2022"},{"issue":"4","key":"10.1016\/j.clon.2025.103937_bib11","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1158\/1078-0432.CCR-21-2750","article-title":"Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement","volume":"28","author":"Bagley","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clon.2025.103937_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noac174.253","article-title":"P11.64.A Long-term follow up and translational data from the ReoGlio phase Ib trial of GM-CSF and intravenous pelareorep (Reovirus) alongside standard of care in GBM","volume":"24","author":"Short","year":"2022","journal-title":"Neuro-Oncol"},{"issue":"2","key":"10.1016\/j.clon.2025.103937_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.clon.2022.09.055","article-title":"Organ Preservation in Rectal Cancer: An Overview of the Dutch Perspective and Recent Developments","volume":"35","author":"Verrijssen","year":"2023","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"2","key":"10.1016\/j.clon.2025.103937_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-097810","article-title":"APPROACH: Analysis of Proton versus Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health - study protocol paper for a phase III multicentre, open-label randomised controlled trial","volume":"15","author":"Slevin","year":"2025","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.clon.2025.103937_bib15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.clon.2023.11.027","article-title":"Hitting the Target: Developing High-quality Evidence for Proton Beam Therapy Through Randomised Controlled Trials","volume":"36","author":"Hudson","year":"2024","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"12","key":"10.1016\/j.clon.2025.103937_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-095560","article-title":"Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) - study protocol paper for a phase III multicentre, open-label randomised controlled trial","volume":"14","author":"Slevin","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.clon.2025.103937_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2025.103912","article-title":"The POINTER-PC Study-determining Optimal Radiotherapy for Pelvic Nodal Recurrence in Prostate Cancer","volume":"46","author":"Slevin","year":"2025","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clon.2025.103937_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.radonc.2021.09.010","article-title":"An international Delphi consensus for pelvic stereotactic ablative radiotherapy re-irradiation","volume":"164","author":"Slevin","year":"2021","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.clon.2025.103937_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.meddos.2021.05.002","article-title":"Ultra hypofractionated extended nodal irradiation using volumetric modulated arc therapy for oligorecurrent pelvic nodal prostate cancer","volume":"46","author":"Slevin","year":"2021","journal-title":"Med Dosim"},{"issue":"3","key":"10.1016\/j.clon.2025.103937_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-078926","article-title":"Brain Re-Irradiation Or Chemotherapy: a phase II randomised trial of re-irradiation and chemotherapy in patients with recurrent glioblastoma (BRIOChe) - protocol for a multi-centre open-label randomised trial","volume":"14","author":"Hudson","year":"2024","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.clon.2025.103937_bib21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.semradonc.2020.02.003","article-title":"To Radiate or Not to Radiate-The Challenges of Pelvic Reirradiation","volume":"30","author":"Kamran","year":"2020","journal-title":"Semin Radiat Oncol"},{"issue":"2","key":"10.1016\/j.clon.2025.103937_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2017.09.030","article-title":"Pelvic re-irradiation using stereotactic ablative radiotherapy (SABR): A systematic review","volume":"125","author":"Murray","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2025.103937_bib23","series-title":"International journal of radiation oncology, biology, physics","first-page":"E164","article-title":"The Development of an Umbrella Trial (PLATO) to Address Radiation Therapy Dose Questions in the Locoregional Management of Squamous Cell Carcinoma of the Anus","author":"Sebag-Montefiore","year":"2016"},{"issue":"6","key":"10.1016\/j.clon.2025.103937_bib24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1470-2045(25)00213-X","article-title":"Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trial","volume":"26","author":"Gilbert","year":"2025","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.clon.2025.103937_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049119","article-title":"A Phase II trial of Higher RadiOtherapy Dose In The Eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trial","volume":"12","author":"Hudson","year":"2022","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.clon.2025.103937_bib26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.radi.2023.01.001","article-title":"Barriers and facilitators to conducting radiotherapy clinical trials: Findings from a UK survey","volume":"29","author":"Hancock","year":"2023","journal-title":"Radiography"},{"issue":"4","key":"10.1016\/j.clon.2025.103937_bib27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.clon.2019.10.004","article-title":"Radiotherapy Trial Set-up in the UK: Identifying Inefficiencies and Potential Solutions","volume":"32","author":"Hanna","year":"2020","journal-title":"Clin Oncol"},{"issue":"5","key":"10.1016\/j.clon.2025.103937_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.clon.2024.01.017","article-title":"The National Radiotherapy Trials Quality Assurance Group \u2013 Driving up Quality in Clinical Research and Clinical Care","volume":"36","author":"Miles","year":"2024","journal-title":"Clin Oncol"},{"issue":"1","key":"10.1016\/j.clon.2025.103937_bib29","article-title":"Boosting and broadening recruitment to UK cancer trials: towards a blueprint for action","volume":"2","author":"Veronica","year":"2023","journal-title":"BMJ Oncol"},{"issue":"1","key":"10.1016\/j.clon.2025.103937_bib30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/s13063-022-06315-8","article-title":"Clinical trial management: a profession in crisis?","volume":"23","author":"Mitchell","year":"2022","journal-title":"Trials"},{"year":"2021","series-title":"Clinical oncology UK workforce census report 2020","key":"10.1016\/j.clon.2025.103937_bib31"},{"year":"2023","series-title":"NOC-rad: neurocognition in oropharyngeal cancer following radiotherapy","key":"10.1016\/j.clon.2025.103937_bib32"},{"issue":"11","key":"10.1016\/j.clon.2025.103937_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-068580","article-title":"Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT)","volume":"12","author":"Zhong","year":"2022","journal-title":"BMJ Open"},{"year":"2014","series-title":"A practical guide to designing phase II trials in oncology","author":"Brown","key":"10.1016\/j.clon.2025.103937_bib34"},{"year":"2024","series-title":"Clinical research statement of intent","key":"10.1016\/j.clon.2025.103937_bib35"},{"year":"2018","series-title":"Strategic review of CRUK\u2019s investment in radiation biology and radiation oncology","key":"10.1016\/j.clon.2025.103937_bib36"},{"issue":"6","key":"10.1016\/j.clon.2025.103937_bib37","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S1470-2045(23)00182-1","article-title":"Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments","volume":"24","author":"McIntosh","year":"2023","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.clon.2025.103937_bib38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/bjc.2016.398","article-title":"Biomarkers in anal cancer: from biological understanding to stratified treatment","volume":"116","author":"Jones","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2025.103937_bib39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejmp.2019.12.017","article-title":"A novel framework for spatial normalization of dose distributions in voxel-based analyses of brain irradiation outcomes","volume":"69","author":"Monti","year":"2020","journal-title":"Phys Med"},{"issue":"1","key":"10.1016\/j.clon.2025.103937_bib40","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41467-024-47195-7","article-title":"A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary","volume":"15","author":"Conway","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.clon.2025.103937_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110071","article-title":"Choosing the right questions - A systematic review of patient reported outcome measures used in radiotherapy and proton beam therapy","volume":"191","author":"Fairweather","year":"2024","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.clon.2025.103937_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clon.2019.09.049","article-title":"Patient Involvement in the Design of a Randomised Trial of Proton Beam Radiotherapy Versus Standard Radiotherapy for Good Prognosis Glioma","volume":"32","author":"Powell","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clon.2025.103937_bib43","series-title":"International clinical trials methodology conference","article-title":"Enhancing Patient and Public Involvement and Engagement (PPIE): Insights from the CONCORDE Phase I Platform Trial","author":"Walker","year":"2024"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093665552500192X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093665552500192X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T23:02:18Z","timestamp":1760655738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093665552500192X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":43,"alternative-id":["S093665552500192X"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2025.103937","relation":{},"ISSN":["0936-6555"],"issn-type":[{"type":"print","value":"0936-6555"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiating Excellence: A Decade of Pioneering Radiotherapy Trials and Collaborative Leadership at Leeds Cancer Research UK Clinical Trials Unit","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2025.103937","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}],"article-number":"103937"}}